High case volume of radiation oncologists is associated with better survival of nasopharyngeal carcinoma patients treated with radiotherapy: A multifactorial cohort analysis

Clinical Otolaryngology

Volumn 36, Issue 6, 2011, Pages 558-565

  Chien, C R ^a,b   Lin, H W ^a,c   Yang, C H ^a   Yang, S N ^a,c   Wang, Y C ^a   Kuo, Y C ^a   Chen, S W ^a,b   Liang, J A ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; RADIATION ONCOLOGY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAIWAN;

EID: 84855167584     PISSN: 17494478     EISSN: 17494486     Source Type: Journal    
DOI: 10.1111/j.1749-4486.2011.02405.x     Document Type: Article

References (25)

1. Hillner B.E., Smith T.J. & Desch C.E. (2000) Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J. Clin. Oncol. 18, 2327-2340.
2. Cheung M.C., Koniaris L.G., Perez E.A. et al. (2009) Impact of hospital volume on surgical outcome for head and neck cancer. Ann. Surg. Oncol. 16, 1001-1009.
3. Guo Z.M., Liu W.W. & He J.H. (2009) A retrospective cohort study of nasopharyngeal adenocarcinoma: a rare histological type of nasopharyngeal cancer. Clin. Otolaryngol. 34, 322-327.
4. Bureau of National Health Insurance. (2011) URL [accessed on 21 February 2011].
5. Department of Statistics, Ministry of Interior. (2011) URL [accessed on 21 February 2011].
6. National Health Insurance Research Database. (2011) URL [accessed on 21 February 2011].
7. Code of Federal Regulations. (2011) URL [accessed 16 February 2011].
8. Lai M.N., Wang S.M., Chen P.C. et al. (2010) Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J. Natl Cancer Inst. 102, 179-186.
9. Chien C.R., Su S.Y., Cohen L. et al. Use of Chinese medicine among survivors of nasopharyngeal carcinoma in Taiwan: a population-based study. Integr. Cancer Ther. (Epub ahead of print).
10. Yabroff K.R., Warren J.L., Schrag D. et al. (2009) Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Med. Care 47, S56-S63.
11. NCCN clinical practice guidelines in oncology. (2011) Head and neck cancer, v.2.2010. URL (free registration required) [accessed on 21 January 2011].
12. Lien H.M., Chou S.Y. & Liu J.T. (2008) Hospital ownership and performance: evidence from stroke and cardiac treatment in Taiwan. J. Health Econ. 27, 1208-1223.
13. Crowley J., LeBlanc M., Jacobson J. et al. (1997) Some exploratory tools for survival analysis. In Lecture Notes on Statistics. Proceedings of the First Seattle Symposium in Biostatistics: Survival Analysis, pp. 199-229. Springer, New York, NY, USA.
14. Rami-Porta R., Ball D., Crowley J. et al. (2007) The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J. Thorac. Oncol. 2, 593-602.
15. Cohen H.J. (2007) The cancer aging interface: a research agenda. J. Clin. Oncol. 25, 1945-1948.
16. Sidler D., Thum P., Winterhalder R. et al. (2010) Undifferentiated carcinoma of nasopharyngeal type (UCNT): a Swiss single-institutional experience during 1990-2005. Swiss Med. Wkly. 140, 273-279.
17. Klabunde C.N., Potosky A.L., Legler J.M. et al. (2000) Development of a comorbidity index using physician claims data. J. Clin. Epidemiol. 53, 1258-1267.
18. Chien C.R., Pan I.W., Tsai Y.W. et al. Radiation therapy after breast-conserving surgery: does hospital surgical volume matter? A population-based study in Taiwan. Int. J. Radiat. Oncol. Biol. Phys. (Epub ahead of print).
19. Chien C.R., Chen S.W., Hsieh C.Y. et al. (2001) Retrospective comparison of the AJCC 5th edition classification for nasopharyngeal carcinoma with the AJCC 4th edition: an experience in Taiwan. Jpn. J. Clin. Oncol. 31, 363-369.
20. Hong R.L., Ting L.L., Ko J.Y. et al. (2001) Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma. J. Clin. Oncol. 19, 4305-4313.
21. Licitra L., Bernier J., Cvitkovic E. et al. (2003) Cancer of the nasopharynx. Crit. Rev. Oncol. Hematol. 45, 199-213.
22. Sze H.C., Ng W.T., Chan O.S. et al. Radical radiotherapy for nasopharyngeal carcinoma in elderly patients: the importance of co-morbidity assessment. Oral Oncol. (Epub ahead of print).
23. Peters L.J., O'Sullivan B., Giralt J. et al. (2010) Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. J. Clin. Oncol. 28, 2996-3001.
24. Pignon J.P., Bourhis J., Domenge C. et al. (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355, 949-955.
25. Kam M.K., Leung S.F., Zee B. et al. (2007) Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J. Clin. Oncol. 25, 4873-4879.